Sight Sciences Inc (NASDAQ:SGHT) — Market Cap & Net Worth
Market Cap & Net Worth: Sight Sciences Inc (SGHT)
Sight Sciences Inc (NASDAQ:SGHT) has a market capitalization of $278.11 Million ($278.11 Million) as of August 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15074 globally and #3548 in its home market, demonstrating a 11.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sight Sciences Inc's stock price $5.26 by its total outstanding shares 52871731 (52.87 Million). See SGHT capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Sight Sciences Inc Market Cap History: 2021 to 2026
Sight Sciences Inc's market capitalization history from 2021 to 2026. Data shows change from $928.96 Million to $278.11 Million (-30.71% CAGR).
Index Memberships
Sight Sciences Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.01% | #408 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1465 of 3165 |
Weight: Sight Sciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sight Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sight Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.41x
Sight Sciences Inc's market cap is 2.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $928.96 Million | $48.96 Million | -$62.96 Million | 18.98x | N/A |
| 2022 | $645.56 Million | $71.33 Million | -$86.24 Million | 9.05x | N/A |
| 2023 | $272.82 Million | $81.06 Million | -$55.55 Million | 3.37x | N/A |
| 2024 | $192.45 Million | $79.87 Million | -$51.51 Million | 2.41x | N/A |
Competitor Companies of SGHT by Market Capitalization
Companies near Sight Sciences Inc in the global market cap rankings as of August 2, 2026.
Key companies related to Sight Sciences Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Sight Sciences Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Sight Sciences Inc's market cap moved from $928.96 Million to $ 278.11 Million, with a yearly change of -30.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $278.11 Million | -33.67% |
| 2025 | $419.27 Million | +117.86% |
| 2024 | $192.45 Million | -29.46% |
| 2023 | $272.82 Million | -57.74% |
| 2022 | $645.56 Million | -30.51% |
| 2021 | $928.96 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Sight Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $278.11 Million USD |
| MoneyControl | $278.11 Million USD |
| MarketWatch | $278.11 Million USD |
| marketcap.company | $278.11 Million USD |
| Reuters | $278.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sight Sciences Inc
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeo… Read more